NCT07371650Phase 2Active not recruiting

This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza

Study sponsor: Traws Pharma, Inc. · TRAW

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-12Estimated
Enrollment · participants105Estimated
Source updated2026-03-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Actual. After: Estimated.

Enrollment · participant count changed

Before: 0 participants (actual). After: 105 participants (planned).

Primary completion date changed

Before: Jun 2026. After: Dec 2026.

Recruitment status changed

Before: Withdrawn. After: Active not recruiting.

Check registry source